Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$5,847,913
+$1,097,222 QoQ
Shares Held
23,026
+18.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#1,497
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hodges Capital Management Inc. holds $30,757,198 across 7 Drug Manufacturers - General names. JNJ ranks #2 (19.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,780 | $12,929,856 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
23,026 | $5,847,913 | |
| 3 | ABBV |
AbbVie Inc.
|
19,642 | $4,942,712 | |
| 4 | AMGN |
Amgen Inc
|
7,363 | $2,666,289 | |
| 5 | NVO |
Novo Nordisk A S
|
51,300 | $2,459,322 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
9,315 | $1,176,857 | |
| 7 | MRK |
Merck & Co., Inc.
|
5,714 | $734,249 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,847,913 | 23,026 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $4,750,691 | 19,435 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $3,574,026 | 17,270 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,005,843 | 16,211 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,383,609 | 9,058 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,496,374 | 9,023 | Shares | Sole | 2025-06-02 | |
| 2024-12-31 | $2,365,549 | 16,357 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $2,828,433 | 17,453 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $2,607,494 | 17,840 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,991,847 | 18,913 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $3,690,913 | 23,548 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,733,639 | 23,972 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,437,922 | 26,812 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $4,718,200 | 30,440 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,123,411 | 40,325 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $5,942,873 | 36,379 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $7,805,469 | 43,972 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $7,924,307 | 44,712 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,940,898 | 46,419 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $7,753,453 | 48,009 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $6,601,461 | 40,072 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $6,961,866 | 42,360 | Shares | Sole | 2021-04-07 | |
| 2020-12-31 | $6,682,040 | 42,458 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $6,626,202 | 44,507 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $5,974,243 | 42,482 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $5,739,428 | 43,769 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||